March 9, 2026
TOPLINE: A high proportion of patients with rheumatoid arthritis (RA) exhibited sleep impairment. Treatment with upadacitinib improved patient-reported sleep quality at 3 months, with benefits sustained […]
March 6, 2026
TOPLINE: The risk for infection in patients with antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis on immunosuppressive therapy is linked to having chronic lung disease as well as […]
March 6, 2026
New data from France suggest that asthma and other atopic conditions may accelerate osteoarthritis progression and increase the likelihood of joint replacement, indicating a possible link […]
March 5, 2026
MELBOURNE, Australia — The underlying histopathologic class of antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis may influence the response to immunosuppressive treatment, according to a presentation at the […]
March 5, 2026
TOPLINE: Patients with ANCA-associated vasculitis who were treated with rituximab showed reduced serological responses to pneumococcal vaccination, but responses improved in those who later received a […]
March 4, 2026
Osteoporosis treatment requires a “long-game strategy” that involves advance planning and sometimes challenging decision-making about sequential therapy, Gina Woods, MD, osteoporosis clinic director at University of […]
March 3, 2026
Children with IgA vasculitis who present with severe persistent skin manifestations, such as hemorrhagic vesicles, ulceration, or necrosis, are at higher risk for relapse and should […]
March 2, 2026
MELBOURNE, Australia — Two-year data from the SELECT-GCA trial of the JAK inhibitor upadacitinib in patients with giant cell arteritis (GCA) suggest the drug can maintain […]
March 2, 2026
TOPLINE: Incident proximal humerus fractures were more common among older adults of Norwegian origin vs those with immigrant backgrounds, unmarried vs married people, and women vs […]